A pragmatic randomized controlled trial of standard care versus steroids plus standard care for treatment of pneumonia in adults admitted to Kenyan hospitals

niversity of Oxford0 个研究点目标入组 2,180 人开始时间: 2022年11月25日最近更新: 2024年3月18日

适应症

试验速览

暂无简介。

•1. Adults aged 18 years or over
•2. Admitted to hospital with a diagnosis of community-acquired pneumonia. Pneumonia will be based on a clinical definition as follows: the presence of at least 2 of the following signs and symptoms for less than 14 days: cough, fever, dyspnea, hemoptysis, chest pain or crackles on chest examination
•3. Admitted to hospital within the previous 48 hours in this current illness
•4. Provides written informed consent

•1. Diagnosis of COVID-19 confirmed via polymerase chain reaction (PCR) of nasopharyngeal/oropharyngeal (NP/OP) swabs or antigen rapid diagnostic tests (RDTs) done at the hospital. This criterion only applies if the test result is known at the point of enrollment
•2. Hospital acquired pneumonia- defined as pneumonia in a patient who has been in hospital for >48 hours who did not have the symptoms at admission
•3. Patients who in the opinion of the attending clinician, require to be treated with steroids.
•4. Known or suspected condition which in the opinion of attending clinician requires treatment with steroids, including but not limited to chronic obstructive pulmonary disease, asthma, adrenal insufficiency, Pneumocystis Jirovecii pneumonia (PCP)
•5. If the clinician strongly suspects COVID-19 and wants to provide steroids to the patient because of this suspicion, then the patient will be excluded from the trial
•6. Pregnancy or breast feeding
•7. Any contraindication to steroid administration

发起方